“…Many pathways are associated with the pathogenesis of CD. [124], TLR8 [125], HTRA3 [126], CEBPB (CCAAT enhancer binding protein beta) [127], CD55 [128], CXCR2 [129], CCL28 [130], CBR3 [131], CCL3 [132], FCGR2A [48], ACSL1 [133], CCL2 [134], SOD2 [135], CD14 [136], IGFBP2 [137], CD274 [138], DERL3 [139], SERPINE1 [140], IDO1 [141], PDK1 [142] [156], TYMP (thymidine phosphorylase) [144], S100P [157], PDPN (podoplanin) [158], ADAMTS1 [159], ATF3 [160], TIMP1 [161], UCN2 [162], SELE (selectin E) [163], ICAM1 [164], FOSL1 [165], AREG (amphiregulin) [166], PIM2 [167], SLC7A5 [168], CH25H [169], COL5A2 [170], SNAI1 [171], MXRA5 [172], EGR1 [173], TNFRSF17 [174], MDFI (MyoD family inhibitor) [175], SRGN (serglycin) [176], CEACAM6 [177], CCL11 [178], IFNG (interferon gamma) [179], TREM2 [180], INHBA (inhibin subunit beta A) [181], APOE (apolipoprotein E) [182], FGR (FGR proto-oncogene, Src family tyrosine kinase) GBP5 [465], HGF (hepatocyte growth factor) [466], CXCL9 [467], SLC11A1 [468], IL1RN [469], STAT1 [470], CYP27B1 [471], MMP1 [472], SOCS3 [473], TLR8 [474], CD55 [475], CCL28 [476], FCGR2A [477], CCL2 [478],...…”